標(biāo)題: Titlebook: Controversies in Oral Cancer; K. Alok Pathak,Richard W. Nason Book 2012 The Editor(s) (if applicable) and The Author(s), under exclusive l [打印本頁] 作者: Lampoon 時(shí)間: 2025-3-21 18:25
書目名稱Controversies in Oral Cancer影響因子(影響力)
書目名稱Controversies in Oral Cancer影響因子(影響力)學(xué)科排名
書目名稱Controversies in Oral Cancer網(wǎng)絡(luò)公開度
書目名稱Controversies in Oral Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Controversies in Oral Cancer被引頻次
書目名稱Controversies in Oral Cancer被引頻次學(xué)科排名
書目名稱Controversies in Oral Cancer年度引用
書目名稱Controversies in Oral Cancer年度引用學(xué)科排名
書目名稱Controversies in Oral Cancer讀者反饋
書目名稱Controversies in Oral Cancer讀者反饋學(xué)科排名
作者: Inferior 時(shí)間: 2025-3-21 21:27 作者: habile 時(shí)間: 2025-3-22 04:22
Mandible-Preserving Alternatives,arcinoma often necessitates its surgical removal. Central mandibular defects, in particular, result in severe cosmetic disfigurement and functional impairment [1]. For almost a century before the pioneering work of Marchetta, even uninvolved mandibles were resected routinely as part of a commando op作者: 帽子 時(shí)間: 2025-3-22 05:18 作者: 男學(xué)院 時(shí)間: 2025-3-22 08:43 作者: Fraudulent 時(shí)間: 2025-3-22 13:01
Current Options and Controversies in Reconstruction of the Oral Cavity, restoring form and function, and changing treatment philosophies have increased the complexity of reconstruction. Reconstructive options have evolved significantly over the past three decades. In the 1980s, pedicle flaps were the mainstay of reconstruction. However, with the introduction of free fl作者: Fraudulent 時(shí)間: 2025-3-22 19:33
Challenges in Preserving Salivary Gland Functions,ith successful treatment modalities. For instance, preserving the function of the salivary glands in patients undergoing radiation for head and neck cancer (HNC) is challenging, but the question is how to achieve this. This chapter explores techniques for preserving salivary gland function in patien作者: habile 時(shí)間: 2025-3-22 23:46 作者: 領(lǐng)巾 時(shí)間: 2025-3-23 04:54 作者: 莊嚴(yán) 時(shí)間: 2025-3-23 08:34 作者: 不妥協(xié) 時(shí)間: 2025-3-23 13:14 作者: predict 時(shí)間: 2025-3-23 14:15
15 Niet geconstateerde fausse route,arcinoma often necessitates its surgical removal. Central mandibular defects, in particular, result in severe cosmetic disfigurement and functional impairment [1]. For almost a century before the pioneering work of Marchetta, even uninvolved mandibles were resected routinely as part of a commando op作者: CRAFT 時(shí)間: 2025-3-23 18:26
M. Hoogland,M. Eli?ns,J. van der Giessen patients from the population-based cancer registry of the province of Manitoba, the 5-year disease-specific survival was 63 %. Survival was 74 % for stage I, 59 % for stage II, 52 % for stage III and 29 % for stage IV disease (p?=?0.0000). A number of factors interacted to determine the outcome in 作者: 向外才掩飾 時(shí)間: 2025-3-24 02:15 作者: flimsy 時(shí)間: 2025-3-24 04:43 作者: Misgiving 時(shí)間: 2025-3-24 07:29
Achtergronden en ontwikkelingen,ith successful treatment modalities. For instance, preserving the function of the salivary glands in patients undergoing radiation for head and neck cancer (HNC) is challenging, but the question is how to achieve this. This chapter explores techniques for preserving salivary gland function in patien作者: EWER 時(shí)間: 2025-3-24 14:22 作者: 指數(shù) 時(shí)間: 2025-3-24 15:51
Motorprogramma versus feedback-controless. In our experience with a cohort of 700 patients with oral cancer in the population-based tumour registry CancerCare Manitoba, 625 were treated with curative intent (R. Nason, 2010, unpublished data). Persistent disease was observed in 50 patients, the majority of whom were treated with radiother作者: 尖 時(shí)間: 2025-3-24 22:17 作者: coalition 時(shí)間: 2025-3-25 00:57
978-81-322-3448-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature India Pr作者: 抗體 時(shí)間: 2025-3-25 06:24 作者: 短程旅游 時(shí)間: 2025-3-25 11:30
Controversies in Oral Cancer978-81-322-2574-4Series ISSN 2364-4060 Series E-ISSN 2364-4079 作者: UNT 時(shí)間: 2025-3-25 13:46
Achtergronden en ontwikkelingen,ith successful treatment modalities. For instance, preserving the function of the salivary glands in patients undergoing radiation for head and neck cancer (HNC) is challenging, but the question is how to achieve this. This chapter explores techniques for preserving salivary gland function in patients undergoing radiation for oral cancers.作者: Organonitrile 時(shí)間: 2025-3-25 18:57
K. Alok Pathak,Richard W. NasonOral cancer is one of the most common forms of head and neck cancer and not surprisingly still has several debatable grey areas and controversies.The present volume of HNCC series on ‘Controversies in作者: 刪除 時(shí)間: 2025-3-25 21:43 作者: 標(biāo)準(zhǔn) 時(shí)間: 2025-3-26 00:56
A.H. van den Meiracker,J. Deinumlling pathways in HNSCC include EGFR, Ras, tumour growth factor-beta (TGF-β), signal transducer and activator of transcription (STAT), Wnt/β-catenin and PI3-K/Akt/mTOR. The aberrant activities of these interrelated signalling pathways contribute to the development of HNSCC. Knowledge of cross-talks 作者: 角斗士 時(shí)間: 2025-3-26 08:01 作者: Palter 時(shí)間: 2025-3-26 09:28 作者: 褪色 時(shí)間: 2025-3-26 16:34
Surveillance After Treatment of Oral Cancer,y-seven second primary tumours were identified in 146 patients. The most frequent site was the head and neck (.?=?100), followed by the lung (.?=?50) and the oesophagus (.?=?7). The overall and cause-specific survival at 5 years was 51 and 63 %. Overall survival by stage of disease was 74 %, 59 %, 5作者: 血統(tǒng) 時(shí)間: 2025-3-26 20:12 作者: corpus-callosum 時(shí)間: 2025-3-27 00:44 作者: Water-Brash 時(shí)間: 2025-3-27 03:28
Book 2012ther as multidisciplinary units. The book is meant for medical students, residents and consultants in various disciplines, including otolaryngology, head and neck surgery, neurosurgery, plastic surgery, maxillofacial surgery and oncology..作者: Hypomania 時(shí)間: 2025-3-27 05:21
2364-4060 rsies.The present volume of HNCC series on ‘Controversies in.This volume brings together the work of experts from clinical and basic sciences specialties and addresses some of the controversial issues and advances in the management of oral cancer. Improving the outcome for the oral cancer patient wi作者: Biomarker 時(shí)間: 2025-3-27 09:39 作者: 無能的人 時(shí)間: 2025-3-27 15:22
https://doi.org/10.1007/978-90-313-9650-4rus (HPV) status have been shown to relate to outcome, thus making for a more accurate estimation of prognosis. Factor analysis has the validity to assess the potential for cure as well as palliative end-points, such as time to treatment failure and estimated survival [2–5].作者: 灰姑娘 時(shí)間: 2025-3-27 19:57
M. Hoogland,M. Eli?ns,J. van der Giessenirst is not a necessity in the timing of lymphadenectomy—the question of elective treatment of the neck versus a ‘wait and watch’ approach. The second is the anatomical extent of treatment, if occult metastatic disease is elected to be treated.作者: AMBI 時(shí)間: 2025-3-27 22:32
Opleiding en professionalisering,[1, 2]. Refinements in flap insetting and advances in other related specialties have led to an overall better quality of life for the patient. This chapter summarizes the current reconstructive options and discusses the major controversies in oral reconstruction.作者: 新義 時(shí)間: 2025-3-28 04:04
Management of the N0 Neck in Oral Cancer,irst is not a necessity in the timing of lymphadenectomy—the question of elective treatment of the neck versus a ‘wait and watch’ approach. The second is the anatomical extent of treatment, if occult metastatic disease is elected to be treated.作者: FUSE 時(shí)間: 2025-3-28 08:16 作者: GLOOM 時(shí)間: 2025-3-28 11:37 作者: PAGAN 時(shí)間: 2025-3-28 14:40
2364-4060 sultants in various disciplines, including otolaryngology, head and neck surgery, neurosurgery, plastic surgery, maxillofacial surgery and oncology..978-81-322-3448-7978-81-322-2574-4Series ISSN 2364-4060 Series E-ISSN 2364-4079 作者: cauda-equina 時(shí)間: 2025-3-28 19:21
6 Hypertensie tijdens de zwangerschap,disorders with increased risk [1]. This chapter will examine oral leukoplakia, oral lichen planus (OLP), erythroplakia and oral submucous fibrosis; the clinical presentation, prevalence and risk factors, histology, molecular genetics, risk of malignant transformation and treatment will be discussed.
